Biotechnology

Life Tech Exploring Potential Sale

Amgen to Build Biotech Manufacturing Plant in Singapore

DSM Announces License Agreement with Amgen

Amgen Trims 2012 EPS Estimate, Citing R&D Tax Credit Delay

Shire Adds to Genetic Disorder Drugs with U.S. Deal

Sartorius, Lonza Announce Collboration on Cell Culture Media

Hookipa Appoints New Members to Management Team

Actelion Sticks to Forecast for Return to Growth from 2014

Celgene Issues 2013, Long-term Forecasts

Genetically Modified Food Labeling Measure to Qualify for Washington State Ballot

Italy's Philogen Signs Drug License Deal with Pfizer

Entering the Age of the $1 Million Medicine

Roche, PSS Team Up to Automate Gene Sample Preparation

U.S. Court Approves Amgen's $762 Million Payment in Drug Case

Amgen Pleads Guilty to Misbranding Charges, Will Pay $762 Million

Russian Billionaire Invests in US Genetics Company 23andMe

Amgen Buys Icelandic Gene Pioneer Decode for $415 Million

U.S. Supreme Court to Decide if Human Genes Patentable

Prof. Stefan Buchholz to head Evonik's R&D group Creavis

German Research Points Way to Faster Flu Vaccines

Sanofi Lets Genzyme's Biotech Culture Call the Shots

GeneQuine Biotherapeutics Closes Seed Financing

Applikon, Thermo Fisher Sign Bilateral Supply Agreement

Dendreon Posts Better-Than-Expected Q3 Results

Europe Approves High-Price Gene Therapy

Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

Nomad Bioscience, Bayer Cropscience to Enter into Strategic Partnership

Biogen Q3 Profit Rises

Celgene Profit Beats Forecasts as Revlimid Delivers

Amgen Q3 Profits Up

Fujifilm Diosynth Biotechnologies, Piramal Announce Strategic Alliance

ThromboGenics Says Main Drug Cleared for U.S. Launch

Focus on New Actelion Drug as Tracleer Sales Slip

Applikon Biotechnology Starts Construction of New Facility in Delft

Evonik Invests Heavily in Biotech

101 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Ontario Int. Marketing Ct.

ACIB Austrian Centre of Industrial Biotechnology

International Sustainable Chemistry Collaborative Centre ISC3

Arthur D. Little

Miebach Consulting GmbH

Farmindustria

Groupe Novasep

SK Pharmteco

Thomson Reuters

BioCampus Straubing

SchüllerConsulting

European Circular Bioeconomy Fund (ECBF)

Henkel AG & Co. KGaA

Beckman Coulter, Inc.

CzechInvest

Olon S.p.A.

WuXi AppTec

Hamilton Bonaduz AG

Evonik Industries AG

Managm. Consult. Chemicals

Messe München GmbH

Rentschler Biopharma SE

Jan Ramakers Fine Chemical

Numaferm GmbH

Jennewein Biotechnologie GmbH

PhytoAR Biotechnologie GmbH

Kaye Scholer

AbbVie Inc.

GEA Liquid Processing

GETEC Group

Novozymes Biopharma UK Ltd.

Dottikon Exclusive Synthesis AG

Bio Consortia

EvaluatePharma

Tufts University

Dechema e.V.

BCNP Consultants GmbH

AstraZeneca